Switzerland

SECO Removes Individuals from Ukraine Sanctions List

Switzerland's State Secretariat for Economic Affairs (SECO) has removed 7 individuals from the sanctions list related to the situation in Ukraine. These amendments to Annex 8 of the ordinance came into force on March 20, 2026, at 11 pm CET.

Swissmedic: Lisdexamfetamine Contraindication for Pheochromocytoma Patients

Swissmedic is updating the contraindications for lisdexamfetamine dimesylate to include patients with pheochromocytoma. This change aims to prevent potentially life-threatening increases in catecholamine levels. The product information for both healthcare professionals and patients will be amended to reflect this new contraindication.

FINMA Invites Thierry Lasseron to Right to be Heard

FINMA has invited Thierry Lasseron to exercise his right to be heard regarding enforcement proceedings. Lasseron is required to provide a Swiss domicile for notification within 15 days of publication, or further communications will be made available at FINMA's offices.

Cytosar (cytarabinum) Barcode Expiry Date Discrepancy Alert

Swissmedic has issued a Health Professional Communication regarding a barcode expiry date discrepancy for Cytosar (cytarabinum) 2g/20ml, batch CT32407B. The date encoded in the 2D barcode on the vial label is incorrect and does not match the legible expiry date printed on the vial.

Yttrium Citrate (90Y)-YMM-1 Failed Sterility Test

Swissmedic has issued a communication regarding Citrate d'Yttrium (90Y)-YMM-1, Suspension for Injection, batch Z008. The batch failed its sterility test after incubation. While no immediate patient danger is expected, affected patients require close monitoring.

Voxzogo (vosoritidum) Packaging Text Error Identified

Swissmedic has identified a packaging text error on Voxzogo (vosoritidum) outer packaging. The incorrect dosage information was printed on specific batches, and affected batches have been identified. The company has issued an information letter detailing the error and corrective actions.

Keppra (Levetiracetam) Syringe Change and Medication Error Risk

Swissmedic and UCB-Pharma AG are issuing a communication regarding a change in the application syringe for Keppra (Levetiracetam) oral solution. A new 5 ml syringe replaces the 3 ml syringe for children aged 6 months to 4 years, requiring healthcare professionals to inform caregivers about the change and proper dosing to prevent medication errors.

Updated Sanctions Notice for ISIL (Da'esh) / Al-Kaida

The Swiss State Secretariat for Economic Affairs (SECO) has updated its sanctions database following a UN sanctions committee decision on February 27, 2026. The update concerns individuals, companies, and organizations linked to ISIL (Da'esh) and Al-Qaeda. This change is directly applicable in Switzerland.

FINMA Orders MBaer Merchant Bank AG Liquidation Due to Money Laundering Controls

Switzerland's FINMA has ordered the liquidation of MBaer Merchant Bank AG due to serious, systematic shortcomings in anti-money laundering controls and enabling clients to circumvent asset freezes. This follows FINMA's withdrawal of the bank's license, which is now effective after the bank withdrew its appeal.

Switzerland Updates Iran Sanctions List

The Swiss Federal Department of Economic Affairs, Education and Research (WBF) has updated annexes and the list of sanctioned individuals, companies, and organizations related to Iran. Financial intermediaries are required to implement prohibitions, freeze assets, and report affected business relationships.